Results 121 to 130 of about 500,835 (209)

Utility of Chemotherapy for Metastatic Melanoma in the Contemporary Era and Experience with Modified Vinblastine-Cisplatin-Temozolomide at a Tertiary Care Center. [PDF]

Biomedicines
Doolittle WKL, Rao R, Johnson M, Tejawinata F, Yoshida A, Rothermel LD, Mangla A.   +6 more
europepmc   +1 more source

Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer. [PDF]

Clin Cancer Res
Dieci MV, Gasparini E, Nicolé L, Schmid P, Zambelli A, Favaretto A, Piacentini F, Bianchi GV, Mion M, Ferro A, Arpino G, Emiliani A, Cinieri S, Zamagni C, Gennari A, Spazzapan S, Sartori D, Zustovich F, Tamberi S, Del Mastro L, de Laurentiis M, Musolino A, Cagossi K, Generali D, Giarratano T, Giovanardi F, De Salvo GL, Conte P, Guarneri V.   +28 more
europepmc   +1 more source

Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platform. [PDF]

Oncoimmunology
Ghosh Halder T, Kelley E, Soria-Bustos J, Thode T, Ng S, Bargenquast T, Weston A, Rodriguez Del Villar R, Kaadige M, Borazanci E, Gordon M, Moser J, Tsai F, Priceman SJ, Forman SJ, Xing Y, Altin JA, Soldi R, Sharma S.   +18 more
europepmc   +1 more source

Standardized Upstream Processing of Ovarian Cancer Surgical Specimens for TIL-Oriented Cellular Workflows. [PDF]

Cancers (Basel)
Biernacka A, Kacperczyk-Bartnik J, Witkowska E, Foremniak J, Bidziński M, Derlatka P, Marynowska J.   +6 more
europepmc   +1 more source

Toxoplasmosis-associated hemophagocytic lymphohistiocytosis during tumor-infiltrating lymphocyte therapy. [PDF]

ASM Case Rep
Odeh T, Quach P, Mostofizadeh A, Hankins JD, Hamilton-Seth R, Gorsline C.   +5 more
europepmc   +1 more source

Commentary: Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma

Frontiers in Immunology
Zhongling Sun, Ran Tan, Huanling Wu, Xiaosheng Fang   +3 more
doaj   +1 more source

Efficacy, safety, and characteristics of adoptive tumor-infiltrating lymphocyte therapy in solid tumours: a systematic review and meta-analysis. [PDF]

Front Oncol
Surendran HP, Gopisetty G, Rajappa SJ, Rao TS, Unnikrishnan MK.   +4 more
europepmc   +1 more source

CD73 targeted combination therapy reverses PD-1 inhibitor resistance in CD73-high PD-L1-negative NSCLC: Evidence from pleural effusion organoids. [PDF]

Glob Med Genet
Ren ZR, Wu L, Huang QL, Cai DX, Peng YL, Tang LB, Li JT, Zhu HY, Xu CR, Lu C, Chen ZH, Deng Y, Lin YJ, Zhou Q.   +13 more
europepmc   +1 more source

Raumordnungsbericht 1980 der Landesregierung Schleswig-Holstein

Raumforschung und Raumordnung, 1981
Til P. Koch
doaj  

Phenotypic and functional characterization of tumor-reactive T cells in malignant pleural effusions. [PDF]

Cancer Immunol Res
Gaiger NS, Coburn J, Lee MN, Zhang L, Chen HL, Woodard GA, Kluger HM, Schoenfeld DA, Lu BY.   +8 more
europepmc   +1 more source